HRALA, Matěj, Juraj BOSÁK, Lenka MICENKOVÁ, Jitka KŘENOVÁ, Matej LEXA, Viktória PIRKOVÁ, Zuzana TOMASTIKOVA, Ivana KOLÁČKOVÁ and David ŠMAJS. Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both In Vitro and In Vivo Conditions. Applied and Environmental Microbiology. WASHINGTON, DC (USA): AMER SOC MICROBIOLOGY, 2021, vol. 87, No 14, p. 1-12. ISSN 0099-2240. Available from: https://dx.doi.org/10.1128/AEM.03121-20.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both In Vitro and In Vivo Conditions
Authors HRALA, Matěj (203 Czech Republic, belonging to the institution), Juraj BOSÁK (703 Slovakia, belonging to the institution), Lenka MICENKOVÁ (703 Slovakia, belonging to the institution), Jitka KŘENOVÁ (203 Czech Republic, belonging to the institution), Matej LEXA (703 Slovakia, belonging to the institution), Viktória PIRKOVÁ (703 Slovakia, belonging to the institution), Zuzana TOMASTIKOVA (203 Czech Republic), Ivana KOLÁČKOVÁ (203 Czech Republic) and David ŠMAJS (203 Czech Republic, guarantor, belonging to the institution).
Edition Applied and Environmental Microbiology, WASHINGTON, DC (USA), AMER SOC MICROBIOLOGY, 2021, 0099-2240.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10606 Microbiology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.005
RIV identification code RIV/00216224:14110/21:00123081
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1128/AEM.03121-20
UT WoS 000693249500022
Keywords in English probiotic; Escherichia; E. coli; bacteriocin; pig; ETEC; STEC
Tags 14110513, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 27/10/2022 13:07.
Abstract
Enterotoxigenic Escherichia coli (ETEC) and Shiga toxin-producing E. coli (STEC) strains are the causative agents of severe foodborne diseases in both humans and animals. In this study, porcine pathogenic E. coli strains (n =277) as well as porcine commensal strains (n = 188) were tested for their susceptibilities to 34 bacteriocin monoproducers to identify the most suitable bacteriocin types inhibiting porcine pathogens. Under in vitro conditions, the set of pathogenic E. coli strains was found to be significantly more susceptible to the majority of tested bacteriocins than commensal E. coli. Based on the production of bacteriocins with specific activity against pathogens, three potentially probiotic commensal E. coli strains of human origin were selected. These strains were found to be able to outcompete ETEC strains expressing F4 or F18 fimbriae in liquid culture and also decreased the severity and duration of diarrhea in piglets during experimental ETEC infection as well as pathogen numbers on the last day of in vivo experimentation. While the extents of the probiotic effect were different for each strain, the cocktail of all three strains showed the most pronounced beneficial effects, suggesting synergy between the tested E. coli strains. IMPORTANCE Increasing levels of antibiotic resistance among bacteria also increase the need for alternatives to conventional antibiotic treatment. Pathogenic Escherichia coli represents a major diarrheic infectious agent of piglets in their postweaning period; however, available measures to control these infections are limited. This study describes three novel E. coli strains producing antimicrobial compounds (bacteriocins) that actively inhibit a majority of toxigenic E. coli strains. The beneficial effect of three potentially probiotic E. coli strains was demonstrated under both in vitro and in vivo conditions. The novel probiotic candidates may be used as prophylaxis during piglets' postweaning period to overcome common infections caused by E. coli.
Links
EF16_013/0001761, research and development projectName: RECETOX RI
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
MUNI/A/1325/2020, interní kód MUName: Biomedicínské vědy
Investor: Masaryk University
ROZV/23/LF13/2019, interní kód MUName: Terapeutický potenciál bakteriocinogenních probiotik v léčbě kolibakterióz
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
ROZV/28/LF15/2020, interní kód MUName: Role bakteriocinů u infekcí močových cest
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 24/7/2024 14:20